Schedule 13G ownership disclosure
Halozyme Therapeutics Inc
Security class unavailable · CUSIP: 40637H109
Event date: 2023-12-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,816,427
- Percent of class
- 2.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-24-000045
- Form type
- SC 13G
- Filer
- HALOZYME THERAPEUTICS, INC.
- CIK
- CIK 1159036
- Filed
- Feb 01, 2024
- Reporting period
- Dec 29, 2023
- Description
- Schedule 13G beneficial ownership